The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation
Michael W. Schuster, Roy Beveridge, Debra Frei-Lahr, Camille N. Abboud, Scott Cruickshank, Michael Macri, Dora Menchaca, Jeannine Holden, Edmund K. Waller
Dive into the research topics of 'The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation'. Together they form a unique fingerprint.